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ABSTRACT: SH3 binding peptides contain polyproline helices and are classiﬁed
according to their binding orientations as N-to-C-terminal or C-to-N-terminal. We
have tested the hypothesis that such a peptide binds in both orientations but with
diﬀerent populations. A focal adhesion kinase (FAK)-derived peptide was tested for
its binding orientation on the Src SH3 domain. Paramagnetic tags were introduced at
several positions on the SH3 domain, and on the basis of the paramagnetic relaxation
enhancements (PREs) of the amide protons, the positions of the paramagnetic
centers were determined. Two peptides were synthesized with 13C-enriched Ala or
Pro, at the N-terminal or C-terminal side of the peptide, and the intermolecular
PREs were measured. The results provide compelling evidence that the FAK-derived
peptide binds the SH3 domain in two orientations. In the major state, the SH3
domain binds the peptide in the N−C orientation, whereas 20% of the time, the
peptide binds in the C−N orientation. We conclude that the distinction between N−
C and C−N orientations, which is based on crystal structures, might be artiﬁcial. The
pseudosymmetric nature of the polyproline helix might allow for binding in both orientations in the solution state.
Src belongs to the non-receptor tyrosine kinase family. TheSrc family of kinases is involved in many cellular processes,
including cell motility, apoptosis, cell adhesion, cell cycle
control, cell diﬀerentiation, and signal transduction.1−7 Src is a
modular protein in which several domains have a function in
the recognition of binding partners. It is 60 kDa in mass and
contains an N-terminal SH4 domain, an SH3 domain, an SH2
domain, a kinase domain, and a C-terminal regulatory region.
The three-dimensional structure of the Src SH3 domain
comprises a sheet of antiparallel β-strands. It also contains a
short helix near the C-terminal end and three loops, namely,
the RT loop (so-called because it generally contains arginine
and threonine residues), the nSrc loop (neuronal isoform), and
the distal loop.
The Src SH3 domains are diverse in their ligand
recognition.8,9 In most cases, they bind to ligands that have a
“PxxP” motif, although they can also bind atypical ligands.10−15
In the PxxP motif, P stands for proline, x preceding the second
proline is generally an aliphatic residue, and the other x stands
for any amino acid residue.16 The ligand binding site on SH3
domains is located between the RT loop and n-Src loop. This
binding site consists of two hydrophobic pockets formed by
highly conserved aromatic residues and interacting with the two
proline residues. The third pocket on the SH3 domain is called
the speciﬁcity pocket and consists of a negatively charged
residue that forms a salt bridge with an oppositely charged
residue, either Arg or Lys,17,18 ﬂanking the core “PxxP” motif of
the ligand. The ligands that contain the PxxP motif typically
adopt a polyproline II (PPII) helical conformation. Because of
its pseudosymmetry, such peptides can bind in two orientations
on the SH3 domain. Crystal structures have shown that
peptides that bind to the SH3 domains of c-Src SH3, PI3K, Abl,
and Fyn tyrosine kinases adopt an N-terminal-to-C-terminal
orientation (N−C),18−21 and these are known as class 1
peptides. In other cases, peptides are in an opposite orientation
(C−N),18,22−24 and these are classiﬁed as class 2 peptides. The
binding orientation of the peptide depends on the relative
positioning of the Arg or Lys residue that is present either N- or
C-terminal of the “PxxP” sequence (+xxPxxP or xPxxPx+),
yielding the N−C or C−N orientation, respectively. In the case
of the c-Src SH3 domain, peptides with diﬀerent relative
positions of arginine bind in these diﬀerent orientations. The
arginine of the peptide makes a salt bridge with an aspartate
residue (D101 in our study).17 Mutation of this aspartate
residue reduced not only the binding aﬃnity but also the
speciﬁcity toward the recognition of peptides.25
Previous work in our group26,27 showed that a focal adhesion
kinase (FAK)-derived peptide was able to bind to the Src SH3
domain. In that work, three peptides were synthesized
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separately with a paramagnetic TOAC spin-label placed at
diﬀerent positions, at the C-terminus, at the N-terminus, and in
the PXXP sequence. The interactions between these peptides
and the 15N-labeled Src SH3 domain were studied to determine
the dynamics of the protein−peptide interaction.26 Although
the complex between the Src SH3 domain and FAK peptide
was weak and transient, it was observed that the peptide binds
in a well-deﬁned position on the protein and not in a dynamic
encounter state. However, the data also showed that a peptide
containing a TOAC spin-label at the C-terminus showed
paramagnetic eﬀects on residue Asp 93 of the Src SH3 domain,
even though this residue was at a considerable distance from
the spin-label. This observation could be explained if two
orientations of peptide binding are possible, with the major
orientation being N−C and a small fraction in the alternative
C−N orientation. That would suggest that the distinction in
two classes of SH3 domains based on peptide orientation does
not reﬂect the true situation in solution and is merely a
consequence of the static nature of crystal structures. To test
this hypothesis and determine the orientation(s) of binding of a
class 1 peptide to the Src SH3 domain, we applied
paramagnetic NMR spectroscopy using several tags. The
combination of paramagnetism with NMR represents a
powerful tool for detecting the presence of minor states in
protein−peptide, protein−protein, and protein−DNA com-
plexes.28−31 The concept of the experiment is shown in Figure
1. A paramagnetic label will aﬀect only part of the peptide if
bound in a single orientation. If it binds in the opposite
orientation during a fraction of the time, the other end of the
peptide should also experience paramagnetic eﬀects.
■ EXPERIMENTAL PROCEDURES
Site-Directed Mutagenesis. Cysteine residues were
introduced into the SH3 domain by mutagenesis of plasmid
pET28aSH326 using the whole-plasmid synthesis method
(QuikChange, Stratagene, La Jolla, CA) with the oligonucleo-
tides listed in Table 1 and their complements.
Protein Production. Escherichia coli BL21 cells were
transformed with wt or mutant pET28aSH3. LB medium (3
mL) was inoculated with fresh transformants. After overnight
incubation, the preculture was used to inoculate a 1 L culture (2
× 500 mL in 2 L Erlenmeyer ﬂasks). The 14N-labeled SH3
domain was produced in LB medium, whereas the 15N-enriched
protein was produced in M9 minimal medium with 15NH4Cl as
the sole nitrogen source. The cultures were incubated at 37 °C
and shaken at 200 rpm. Gene expression was induced by
addition of isopropyl β-D-1-thiogalactopyranoside (0.5 mM)
when the culture was at an OD600 of 0.6. The cultures were
harvested 4 h after induction by centrifugation at 3439g, and
the pellets were resuspended in lysis buﬀer containing 20 mM
Tris-HCl (pH 8), 0.5 M NaCl, 10 mM imidazole, and 1 mM
phenylmethanesulfonyl ﬂuoride. The resuspended pellets were
ﬂash-frozen using liquid N2 and stored at −80 °C.
Protein Puriﬁcation. Immediately before lysis of the cells,
25 μg/mL DNase was added to the resuspended culture. The
cells were lysed when the suspension was passed through a
French press twice at a pressure of 1000 psi. The lysate was
cleared by ultracentrifugation at 40000 rpm (192700g) for 40
min. The supernatant was further cleared by passing the sample
through a ﬁlter (0.4 μm) and loaded on a nickel aﬃnity column
(HisTrap HP, GE Healthcare), which had been pre-
equilibrated with a loading buﬀer containing 20 mM Tris-
HCl (pH 8), 0.5 M NaCl, and 10 mM imidazole. The protein
was eluted by applying an imidazole gradient from 10 to 500
mM. The eluted protein was pooled, concentrated to 5 mL, and
loaded on a Superose 12 (10 mm × 300 mm) gel ﬁltration
column, pre-equilibrated with a buﬀer containing 20 mM KPi
(pH 6.5) and 100 mM NaCl (NMR buﬀer). The purity was
shown to be >95% by 15% sodium dodecyl sulfate−
polyacrylamide gel electrophoresis. The concentration of the
protein was measured at 280 nm, using the theoretical
extinction coeﬃcient of 16960 M−1 cm−1.
Peptide Synthesis. Peptides with the sequence RALPSI-
PKLA were prepared by Fmoc chemistry using preloaded
Tentagel resins, benzotriazol-1-yl-oxy-tris-pyrrolidino-phospho-
nium hexaﬂuorophosphate/N-methylmorpholine (PyBop/
NMM) for in situ activation, and 20% piperidine in N-
methyl-2-pyrrolidone (NMP) for Fmoc removal.32 Couplings
were performed for 75 min. After ﬁnal Fmoc removal, peptides
were cleaved with a 19/1 triﬂuoroacetic acid (TFA)/H2O
mixture and isolated by diethyl ether/pentane precipitation.
The peptides were stored at −20 °C until they were used. The
purity of the peptides was checked using reversed-phase high-
performance liquid chromatography and their integrity using
mass spectrometry. Peptide stock solutions were prepared by
weighing out the peptide, dissolving it in NMR buﬀer, and
adjusting the pH by the addition of small aliquots of NaOH or
HCl. Isotope-labeled Fmoc amino acids were purchased from
Sigma-Aldrich Chemie B.V. (Zwijndrecht, The Netherlands).
Paramagnetic Probe Attachment. A double-cysteine
SH3 mutant was used for attachment of a Caged Lanthanoid
NMR Probe (CLaNP-5),33,34 whereas MTSL [(1-oxyl-2,2,5,5-
tetramethylpyrrolidin-3-yl)methyl)-methanethiosulfonate] was
linked to the single-cysteine mutants. First, the SH3 mutant
protein was incubated with 5 mM DTT for 60 min at room
temperature. The DTT was removed by passing the protein
over a PD10 column (GE Healthcare). Ten molar equivalents
of CLaNP-5 or spin-label were added immediately to the eluted
protein, and the solution was incubated for 2 h at room
temperature. The protein was then loaded on a Superdex G75
Figure 1. Experimental approach. The SH3 domain is tagged with a
paramagnetic center, and the peptide is isotope-labeled and observed
in NMR experiments. If the peptide spends a small fraction of the time
in the C−N orientation, paramagnetic relaxation enhancement should
be observed for nuclei at both ends of the peptide.
Table 1. Primers Used To Create Mutations on the SH3
Domaina
T116C/
E117C
GCAGATTGTTAACAACTGCTGCGGGGACTGGTGGC
T98C TATGAGTCACGGTGTGAGACTGACCTG
T100C TCACGGACAGAGTGTGACCTGTCCTTC
L91C ACCTTTGTGGCCTGTTATGACTATGAG
aThe codons for cysteine are shown in bold.
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gel ﬁltration column to remove dimers and oligomers, as well as
excess probe or spin-label. The protein was eluted using NMR
buﬀer [20 mM KPi (pH 6.5) and 100 mM NaCl]. Probe
attachment was conﬁrmed by mass spectrometry, and the
percentage of the paramagnetic spin-label (MTSL) was
determined by electron paramagnetic resonance (EPR). The
double integral of EPR signals measured for all mutants of SH3-
MTSL versus a standard sample of free MTSL indicated that
>95% of the protein was labeled with MTSL. The protein was
concentrated and used for further NMR measurements. For the
double-cysteine mutant, CLaNP-5-Gd was used to observe
paramagnetic eﬀects and CLaNP-5-Lu served as the diamag-
netic control. For the single-cysteine mutants, MTS [(1-acetyl-
2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-methanethiosulfo-
nate] was used as the diamagnetic control.
NMR Experiments. For all NMR experiments, the protein
concentration was 50−200 μM, the concentrations of the
peptide stocks were 5 mM, and the peptides were dissolved in
NMR buﬀer. The pH was adjusted to 6.5 with small aliquots of
0.1−0.5 M solutions of NaOH or HCl. Intramolecular PREs in
the SH3 domain were determined by recording [1H,15N]
HSQC spectra. Intermolecular PREs between the Src SH3
domain and the peptide were obtained from [1H,13C] constant
time HSQC (CT-HSQC) NMR experiments to achieve the
high spectral resolution and ensure reliable calculations of
PREs. Relaxation delays of 1.5 s were used. The constant time
period was set to 26 ms. NMR experiments were recorded on a
Bruker DMX or Avance III 600 MHz NMR spectrometer,
equipped with a TCI-Z-GRAD cryoprobe at 298 K. NMR data
were processed using nmrPipe35 and analyzed using CCPN
Analysis 2.1.5.36 The Src SH3 domain resonances were assigned
with the help of assignments reported for the chicken Src
SH3−SH2 domains.37 The transverse relaxation rate of
resonances in the diamagnetic sample (Rdia
H ) was determined
after processing with a 2 Hz line-broadening exponential
window function. The line width at half-maximum, Δυ1/2, was
calculated from a Lorentzian line shape ﬁt using the software
FuDA (http://pound.med.utoronto.ca/software.html).
After correction for the artiﬁcial line-broadening, the Rdia
H was
obtained from eq 1.
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The rate of transverse relaxation of protons due to the
paramagnetic enhancement eﬀect (R2,para
H ) was calculated using
eq 238 for protein amide protons and eq 3 for peptide carbon-
bound protons. Equation 3 is an extension of eq 2. In 1H−15N
spectra, the paramagnetic transverse relaxation of 15N is
neglected, because 15N is 100-fold less sensitive for PRE than
1H. For 13C nuclei, this factor is only 16, and furthermore, in
the CT experiments, the 13C spends a relatively long time in the
transverse plane; thus, the 13C relaxation contributes signiﬁ-
cantly to the intensity reduction of the HSQC peak.
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where Ipara and Idia are the paramagnetic and diamagnetic peak
intensities, respectively, and ΔH and ΔC are the times that the
1H and 13C magnetization coherences, respectively, are in the
transverse plane during the CT-HSQC experiment (14.4 and
26 ms, respectively). R2,para
C was taken to be equal to R2,para
H /16.
Distances were derived from R2,para
H using eq 4:
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where γH is the gyromagnetic ratio of
1H, g is the electronic g
factor, β is the Bohr magneton, μ0 is the permeability of a
vacuum, S is the spin quantum number of the paramagnet, and
ωH is the proton Larmor frequency. The rotational correlation
time τc of the protein−peptide complex was estimated to be 5
ns, using the software hydroNMR39 and a structure of chicken
Src SH3 bound to a similar peptide [RALPPLPRY, Protein
Data Bank (PDB) entry 1RLQ].17 The R2,para
H values obtained
with eq 3 for peptide nuclei are a population-weighted average
of PREs in the free peptide (no PRE) and the bound form, so
they were ﬁrst extrapolated to the 100% bound form of the
peptide. For example, the concentrations of peptide and
CLaNP-tagged SH3 T116C/E117C were 160 and 80 μM,
respectively. With a Kd of 316 μM, it can be calculated that the
fraction of bound peptide is 15%, so the observed PREs were
divided by 0.15.
Positioning the Paramagnetic Centers. PDB entry
1RLQ was modiﬁed by mutating the peptide to the FAK
sequence RALPSIPKLA, which constitutes residues 368−377
in Uniprot entry Q05397 for human FAK. Here, the peptide
amino acids are numbered from 1 to 10. The sequences of
mouse Src SH3 and chicken Src SH3 are the same except for
residue Thr 127 in the mouse form, which is Ser in the chicken
form. In structure 1RLQ, this residue was changed to Thr in
the docking calculations. To determine the positions of the
paramagnetic centers, a pseudoatom was docked on the SH3
protein on the basis of the distances derived from protein PREs
by using Xplor-NIH.40 An example of a script used for docking
is included in the Supporting Information. On the basis of the
ratios of Ipara and Idia, the nuclei were divided into three classes.
In class 1 were those for which the resonance disappeared in
the paramagnetic spectrum. The ratio for these nuclei was
deﬁned by using the noise level of the paramagnetic spectrum
as the value of Ipara. The nuclei in class 2 had ratios of Ipara and
Idia between 0 and 0.9 and the nuclei in class 3 were those that
had ratios of Ipara and Idia of >0.9. For these, Ipara was set to 0.9
to obtain a minimum distance. Class 1 nuclei yielded distance
restraints to the paramagnetic center with only an upper bound,
class 2 with upper and lower bounds (the calculated distance
with an estimated error of ±3 Å), and class 3 with only a lower
bound. For T98C and T100C, two positions were calculated,
representing the two forms observed for the MTSL-bound SH3
domain (see below). The PRE-derived distances from the
MTSL oxygen atom at these two positions to nuclei in the
peptides were averaged (r−6), because the peptides sample
multiple SH3 molecules rapidly (fast exchange regime).
Fit Quality. The agreement between observed and back-
calculated NMR observables (O) was expressed in a quality
factor, Q, given in eq 5.41 Note that the observed and calculated
observables are added in the denominator. Only class 2
restraints were used to calculate Q.
=
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■ RESULTS AND DISCUSSION
To study the interaction of the mouse Src SH3 domain with the
SH3 binding motif RALPSIPKLA of FAK, paramagnetic
centers were attached to the SH3 domain. The sites of
introduction of single cysteine residues and a cysteine pair, for
attachment of MTSL spin-labels and the lanthanoid probe
CLaNP-5,33,34 respectively, are shown in Figure 2.
Eﬀects of Probe Attachment on the SH3−Peptide
Interaction. To verify the inﬂuence of paramagnetic probes
attached to the SH3 domain on binding of the FAK peptide,
the dissociation constants (Kd) for each mutant were
determined by SH3 amide chemical shift titrations for the
complexes of the peptide and the SH3 domain linked to
diamagnetic control probes, Lu-CLaNP-5 or MTS (Figure S1
of the Supporting Information). With the obtained Kd values,
the CSP values were extrapolated to 100% bound SH3 and the
averaged amide CSP values were mapped on the SH3 structure
for comparison to the wt SH3 binding map (Figure 3 and
Figure S2). The Kd value of mutant L91C (53 ± 1 μM) for
peptide binding is very similar to that of wt SH3 (63 ± 3 μM).
For mutants T100C and T116C/E117C, the Kd values were 3-
and 5-fold larger, respectively. For T98C, MTS(L) attachment
resulted in doubling of 15 peaks. The pairs of peaks had about
the same intensity, suggesting that spin-label binding results in
two conformations that are in slow exchange and equally
populated. Both forms were able to bind the peptide, with Kd
values of 191 ± 11 μM (conformer A) and 393 ± 18 μM
(conformer B), and show very similar chemical shift
perturbation patterns. As the two forms could be distinguished
on the basis of their diﬀerence in aﬃnity for the peptide, they
were treated separately in further experiments. Also for T100C,
a few peaks were doubled, suggesting that the spin-label at this
position assumes two orientations. A titration experiment
indicated that the aﬃnity for the peptide was almost the same
for both conformers. The binding maps for all variants bound
to MTS closely resemble the map of wt SH3 (Figure 3). The
extrapolated CSP values for SH3 attached to CLaNP are
smaller than for wt, but the binding pattern is similar. Thus, we
conclude that probe attachment has some eﬀects on the
strength of the binding interaction, but the speciﬁcity of
binding remains unaﬀected, based on the CSP values.
Localization of the Paramagnetic Centers on the SH3
Domain. The positions of the paramagnetic centers relative to
the protein were determined. For this purpose, the protein was
enriched with 15N and the peptide was added in 5-fold access to
push the binding equilibrium to the bound state of the protein.
[1H,15N] HSQC spectra were recorded for each SH3 variant of
the diamagnetic control samples (Lu-CLaNP-5-SH3−peptide
and MTS-SH3−peptide complexes) as well as the paramagnetic
samples (Gd-CLaNP-5-SH3−peptide and MTSL-SH3−peptide
complexes). The ratios between the intensity of the para-
magnetic peak, Ipara, and that of the diamagnetic peak, Idia, of
the amide resonances (Figure S3) were used to calculate the
distances between each amide proton and the corresponding
paramagnetic center. With these distances, the position of the
paramagnetic center relative to the protein was determined
(Figure S4; see Experimental Procedures for details). The
Figure 2. Probe attachment sites. (A) Amino acid sequence of the
mouse Src SH3 domain. The residues colored red were mutated
individually to Cys, except for the T116C/E117C mutant, which was a
double Cys mutation. The numbering is based on Uniprot entry
Q80XU2 and used throughout. The numbering in PDB entry 1RLQ17
diﬀers by −78. (B) Three-dimensional representation of the SH3
domain (green ribbon) bound to a class 1 peptide (green coil, PDB
entry 1RLQ). The cysteine substitutions for the attachment of
paramagnetic probes have been modeled and are shown in stick
representation, with black labels. The peptide modeled in the C−N
orientation is colored yellow. The peptide residues that were labeled
with 13C are shown as sticks and labeled in the color of the peptide.
The N- and C-termini of the peptides are indicated.
Figure 3. Amide chemical shift perturbations [ΔδAvg = (1/2ΔδH2 +
ΔδN2/50)1/2] of the SH3 domain upon binding of FAK peptide. The
shift changes are extrapolated to 100% bound SH3. The colors
represent the size of ΔδAvg: red for ΔδAvg ≥ 0.25 ppm, orange for 0.25
ppm > ΔδAvg ≥ 0.15 ppm, yellow for 0.15 ppm > ΔδAvg ≥ 0.05 ppm,
and blue for ΔδAvg < 0.05 ppm. Unassigned residues and residues
broadened upon peptide binding are colored gray. Probe attachment
sites are colored cyan.
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distances from the metal or oxygen atom to the Cα atoms of
the cysteines are listed in Table S1. For the spin-labels on
T98C and T100C, two positions were calculated, representing
the two forms in slow exchange.
PREs of the 13C-Labeled Peptide in Complex with the
SH3 Domain. Two versions of the FAK peptide were
synthesized, with 13C-labeled Ala and Pro residues close to
the N-terminus, RALPSIPKLA (peptide 1, labeled residues
underlined), and the C-terminus, RALPSIPKLA (peptide 2).
13C HSQC spectra were recorded for the free peptide and in
the presence of the SH3 domain with a 5-fold molar excess of
the peptide (Figure 4 and Figure S5). Nine resonances are
expected in the 1H dimension, two from Ala (Hα and Hβ) and
seven from Pro (Hα, Hβ2 and -3, Hγ2 and -3, and Hδ2 and -3),
as well as some weak natural abundance signals. However, it
turned out that the peptide occurs in three forms. In the free
form, a major form and a minor form are detected. When SH3
binds, the minor form is not aﬀected. The major form splits
into two peaks, one that shifts proportionally with the fraction
peptide bound and another that remains at the position of free
peptide. We interpret this observation as follows. Three forms
are present, and these forms exchange slowly on the NMR time
scale. Only one of these is capable of binding to the SH3
domain, and this process is in the fast exchange regime. The
Figure 4. [13C,1H] CT-HSQC spectrum of the FAK peptide (RALPSIPKLA, 13C-labeled residues underlined). (A) Spectrum of the free peptide
with assignments for Ala2 and Pro4. Form 1 comprises the transPro4-transPro7 and transPro4-cisPro7 forms. Form 2 represents the cisPro4-
transPro7 form of the peptide. Assignments are listed in Table S2. (B) Detail of panel A showing the Pro4 Hδ protons as well as form 1 of the Pro7
Hδ protons at natural abundance. (C and D) The same spectral region as in panel B is shown of the peptide in the presence of SH3 domain T98C-
MTS (C) and T98C-MTSL (D). (E) Detail of the same samples as in panels C and D, showing the overlay of spectra with SH3 domain T98C-MTS
(blue) and T98C-MTSL (red) for the Hγ2/3 peak. The peptide and SH3 domain concentrations were 1 and 0.2 mM, respectively.
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13C chemical shifts of the three forms (Table S2) indicate that
both proline residues can assume a cis conformation, which can
be deduced from the characteristic chemical shift diﬀerences of
the β and γ nuclei. The relative peak intensities indicate a
population of ∼8% for each cis Pro-containing peptide. In the
major form (84%), both prolines are in the trans conformation.
The double cis conformation is expected to have a population
that is too small to be observed. The double trans form is the
one that binds to the SH3 domain. For peptide 1, in which
Pro4 is labeled, transPro4-transPro7 and transPro4-cisPro7
have the same chemical shifts, but only transPro4-transPro7
binds to the SH3 domain, causing a splitting of the major peak
(form 1). The analogous situation is observed for peptide 2.
The peak intensities in the spectra of the peptide in the
presence of either MTS- or MTSL-labeled SH3 domain were
compared to obtain the Ipara/Idia ratio (Figure 5). As a
consequence of the partial overlap between the peaks of the
diﬀerent forms, the PREs of only a subset of signals could be
determined. The peptide was in excess of the protein and is
only partly bound. Consequently, the PREs are a weighted
average of the free (no PRE) and bound states. Thus, the PREs
calculated from the Ipara/Idia ratios were extrapolated to the
100% bound state using the Kd values and converted into
distances.
Fraction of the Peptide in the C−N Orientation. From
the experimentally calculated positions of the Gd ion in
CLaNP-5 and the oxygen atoms of MTSL at various sites on
the SH3 domain, the distances to peptide nuclei were
calculated for N−C as well as C−N orientations. For the N−
C peptide, PDB entry 1RLQ17 was used, with the peptide
sequence adjusted to that of the FAK peptide. Because only Pro
and Ala residues were used to obtain distances, the nature of
the remaining side chains is expected to have only a weak
inﬂuence. For the C−N orientation, the peptide was rotated
from the N−C to the C−N terminal orientation, ensuring that
both prolines still lie in the binding pocket of the SH3 domain
(Figure 2). This rotated peptide thus mimics class 2 peptides,
which bind in the C−N orientation. The experimental distances
were compared with weighed averages of the distances for
combinations of the N−C and C−N orientations. For the range
of fractions of the C−N orientation from 0 to 1, the ﬁt to the
experimental distances was calculated and expressed as a quality
factor Q (eq 5). The results for the diﬀerent spin-label mutants
are shown in Figure 6. The data for mutant T116C/E117C
clearly show that the ﬁt to the data improves by admixture of
the C−N orientation. This is caused by the PREs observed for
the C-terminally labeled peptide. The lowest value of Q was
found for a combination of 80% N−C orientation and 20% C−
N orientation. These results are similar for mutants T98C and
T100C. For mutant L91C, small but signiﬁcant PREs were
observed for peptide 2 but insigniﬁcant eﬀects for peptide 1.
The small eﬀects cause considerable uncertainty in the
distances and render the Q dependence on the fraction of
C−N rather ﬂat, but the data do not disagree with a
contribution to the PREs from the C−N orientation of ∼20%.
The peptide derived from the FAK binding motif of the Src
SH3 domain belongs to the class 1 sequence (N−C
orientation). PREs derived from the paramagnetic centers on
mutants T116C/E117C, T98C, and T100C suggest that the
peptide binds for 80% of the time in the N−C orientation and
20% in the C−N orientation. Although the data suggest that
the N−C conformation is not populated 100% of the time, and
the C−N conformation contributes signiﬁcantly, some caution
in the interpretation of data is necessary. The model for the C−
N orientation is crude, because it is not known how the FAK
peptide binds exactly to the Src SH3 domain in that
orientation. It is likely, though, that the nuclei that were
labeled, in particular the Pro residues, are modeled in
approximately the correct position, because the location of
the Pro residues in the C−N orientation mirrors that in the N−
C orientation.
The binding maps are similar, but the aﬃnity for the peptide
of the variants with probes was weaker than for the wt SH3
domain. Also, two forms were observed for T98C and T100C,
indicating that the SH3 domain assumes two conformations
that diﬀer slightly and are in slow exchange. Apparently,
attachment of the probe to the small protein domain SH3 can
easily aﬀect its structure, and thus its interaction with the
peptide. Therefore, the possibility that the introduction of the
paramagnetic center inﬂuences the fraction of the peptide that
binds in the C−N orientation cannot be excluded. However, we
ﬁnd consistently a fraction of 20−30% of the C−N
conformation for all the probes at diﬀerent positions,
strengthening the conclusion that the peptide binds in two
orientations. It is noted that in strict terms, the reported Kd
Figure 5. Paramagnetic relaxation of peptide nuclei. The ratios of Ipara
and Idia of the
13C side chain protons of peptide 1 (RALPSIPKLA, left)
and peptide 2 (RALPSIPKLA, right) are plotted. Nuclei with intensity
ratios of <0.9 (···) were considered to experience a signiﬁcant PRE.
The solid line indicates a ratio of 1.0.
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values are apparent Kd values, because the peptide binds in two
orientations. However, the binding is in fast exchange on the
NMR time scale, so the Kd is the weighted average aﬃnity for
both orientations.
It remains to be established whether both binding modes are
functionally relevant. The FAK SH3 binding site is separated
from the SH2 binding site (Tyr397) by a linker of 23 amino
acids, which is likely to be ﬂexible. Earlier work from our group
showed that this linker can be severely reduced in length while
maintaining combined binding to the SH3−SH2 construct of
Src.27 Thus, it seems not impossible that the SH3 binding
sequence has suﬃcient freedom to bind in both the C−N and
N−C orientations without compromising the binding of the
SH2 domain to FAK.
In previous work, the peptide was labeled with a para-
magnetic center by introducing a TOAC residue into the
peptide.26 These studies showed that the peptide bound in a
well-deﬁned orientation despite the moderate aﬃnity. This is in
contrast with some low-aﬃnity protein complexes in which the
partners are in a dynamic encounter state for a signiﬁcant
fraction of the time. This conclusion was based on the well-
deﬁned CSP map and the localized paramagnetic eﬀects caused
by the TOAC radical on the SH3 domain. The ﬁndings in the
present study are not in contrast with that conclusion. Our data
suggest that the peptide binds in two well-deﬁned orientations,
with a major state and a minor state. Such a situation causes
localized CSP of a large size as well as PREs averaged (r−6) over
the two orientations. In encounter complexes, the CSP values
are small because of the averaging and perhaps a lack of
desolvation and PREs are usually observed over a wide area of
the surface, because of the many diﬀerent orientations
occurring in that state.
Binding of the peptide to the SH3 domain in two
orientations implies that the classiﬁcation into N−C and C−
N orientations is a gradual rather than absolute one. Although
SH3 domains share general features such as binding to PxxP
motives, they vary in interaction speciﬁcity and preference for a
speciﬁc class of peptides. Thus, our ﬁnding for the Src SH3
domain will need to be tested on other SH3 domains to be
generalized. Crystal structures are expected to consist of one of
the two forms, but it would be worth re-evaluating NMR
spectra to see whether minor NOEs between the SH3 domain
and the peptide in the minor orientation can be detected.
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■ ABBREVIATIONS
CLaNP, caged lanthanoid NMR probe; CSP, chemical shift
perturbation; DTT, dithiothreitol; EDTA, ethylenediaminete-
traacetic acid; EPR, electron paramagnetic resonance; Fmoc,
9H-ﬂuorenylmethyloxycarbonyl; HEPES, 4-(2-hydroxyethyl)-1-
Figure 6. Determination of the fraction of the C−N orientation of
FAK peptide binding to the SH3 domain. The graphs on the left
represent the correlation between experimental distances derived from
PREs and calculated distances from the structure models of the
peptide bound to the SH3 domain in the C−N and N−C orientations.
The solid and dashed black lines represent the perfect correlation and
the 3 Å error margins, respectively. The graphs on the right show the
quality of the ﬁt to the experimental distances expressed as the Q value
(eq 5) as a function of the fraction of the C−N orientation.
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piperazineethanesulfonic acid; HSQC, heteronuclear single-
quantum coherence; INEPT, insensitive nuclei enhanced by
polarization transfer; Kd, dissociation constant; LB, Lysogenic
Broth; MTS, (1-acetyl-2,2,5,5-tetramethyl-3-pyrroline-3-meth-
yl)-methanethiosulfonate; MTSL, (1-oxyl-2,2,5,5-tetramethyl-
pyrroline-3-yl)methyl)-methanethiosulfonate; NMR, nuclear
magnetic resonance; NOE, nuclear Overhauser eﬀect; SH, Src
homology; TOAC, 2,2,6,6-tetramethylpiperidine-1-oxyl-4-
amino-4-carboxylic acid; wt, wild type; KPi, potassium
phosphate; Tris-HCl, trisaminomethane hydrochloride; PPII,
polyproline type II helix structure.
■ REFERENCES
(1) Sen, B., and Johnson, F. M. (2011) Regulation of SRC family
kinases in human cancers. J. Signal Transduction 2011, 865819.
(2) Martin-Perez, J., Garcia-Martinez, J. M., Sanchez-Bailon, M. P.,
Mayoral-Varo, V., and Calcabrini, A. (2015) Role of SRC family
kinases in prolactin signaling. Adv. Exp. Med. Biol. 846, 163−188.
(3) Pawson, T., and Nash, P. (2003) Assembly of cell regulatory
systems through protein interaction domains. Science 300, 445−452.
(4) Pawson, T. (2004) Specificity in signal transduction: from
phosphotyrosine-SH2 domain interactions to complex cellular
systems. Cell 116, 191−203.
(5) Li, S. S. C. (2005) Specificity and versatility of SH3 and other
proline-recognition domains: structural basis and implications for
cellular signal transduction. Biochem. J. 390, 641−653.
(6) Pawson, T., Gish, G. D., and Nash, P. (2001) SH2 domains,
interaction modules and cellular wiring. Trends Cell Biol. 11, 504−511.
(7) Waksman, G., Kumaran, S., and Lubman, O. (2004) SH2
domains: role, structure and implications for molecular medicine.
Expert Rev. Mol. Med. 6, 1−18.
(8) Saksela, K., and Permi, P. (2012) SH3 domain ligand binding:
What’s the consensus and where’s the specificity? FEBS Lett. 586,
2609−2614.
(9) Siligardi, G., Ruzza, P., Hussain, R., Cesaro, L., Brunati, A. M.,
Pinna, L. A., and Donella-Deana, A. (2012) The SH3 domain of HS1
protein recognizes lysine-rich polyproline motifs. Amino Acids 42,
1361−1370.
(10) Polverini, E., Rangaraj, G., Libich, D. S., Boggs, J. M., and
Harauz, G. (2008) Binding of the proline-rich segment of myelin basic
protein to SH3 domains: spectroscopic, microarray, and modeling
studies of ligand conformation and effects of posttranslational
modifications. Biochemistry 47, 267−282.
(11) Aitio, O., Hellman, M., Kazlauskas, A., Vingadassalom, D. F.,
Leong, J. M., Saksela, K., and Permi, P. (2010) Recognition of tandem
PxxP motifs as a unique Src homology 3-binding mode triggers
pathogen-driven actin assembly. Proc. Natl. Acad. Sci. U. S. A. 107,
21743−21748.
(12) Aitio, O., Hellman, M., Kesti, T., Kleino, I., Samuilova, O.,
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